News and Press Releases
Promega Corporation is a global biotechnology company headquartered in Madison, WI, with branches in 16 countries. Our products and technologies are used to support scientific advances in academic, pharmaceutical, clinical, forensic and industrial/environmental labs worldwide.
News From Your Region
2024
Promega Named a BioSpace 2025 Best Places to Work WinnerNovember 13 • 2 min read
Promega and QuantumCyte Sign Co-Marketing Agreement, Present Joint Poster at Association for Molecular Pathology (AMP) 2024 MeetingNovember 12 • 2 min read
Promega Unveils GloMax® Galaxy Bioluminescence Imager for Illuminating Protein Dynamics in Real TimeOctober 1 • 2 min read
Promega Engineers New Enzyme to Significantly Reduce Stutter in Forensic DNA AnalysisSeptember 25 • 2 min read
Promega Fall Art Showcase Presents “From This Place: Three Photographers”August 6 • 2 min read
35th International Symposium on Human Identification (ISHI) Highlights Intersection of True Crime Media and DNA ForensicsJuly 31 • 2 min read
Promega Maxwell® DE System Accelerates Sexual Assault Kit Processing with Automated ProtocolJuly 9 • 2 min read
Promega Launches Portable 96-Well Plate Reader to Analyze Luminescent Cell Health AssaysJune 11 • 2 min read
Promega Contributes to New Study on Reversible, Non-Hormonal Male ContraceptionJune 4 • 2 min read
Promega Summer Art Showcase Presents “Collections Unveiled”May 23 • 2 min read
Promega Highlights Progress in Sustainability, Employee Wellbeing and Community Engagement in 2024 Corporate Responsibility ReportMay 22 • 2 min read
Promega Kit Enables European Forensic Labs to Solve Challenging Cold CasesMay 7 • 2 min read
INOVIQ and Promega Sign Global Supply and Distribution Agreement for EXO-NET®April 18 • 2 min read
Promega Spring Art Showcase 2024 Presents “Visions of Consciousness”February 15 • 2 min read
eLabNext Partners with Promega to Make Product Protocols Accessible for eLabProtocols UsersJanuary 16 • 2 min read
Promega Research Shows Potential of Selective Degrader Against Pediatric Cancer Cell LinesJanuary 16 • 2 min read
2023
BioLabs and Promega announce collaboration to support young biotech companiesDecember 14 • 2 min read
Promega Named a BioSpace 2024 Best Places to Work WinnerNovember 8 • 2 min read
Live-Cell Assays Reveal Two Reported Anti-Inflammation Molecules Fail to Engage Target ProteinOctober 25 • 2 min read
Promega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in collaboration with GSKOctober 3 • 2 min read
2024
Promega Named a BioSpace 2025 Best Places to Work WinnerNovember 13 • 2 min read
Promega and QuantumCyte Sign Co-Marketing Agreement, Present Joint Poster at Association for Molecular Pathology (AMP) 2024 MeetingNovember 12 • 2 min read
Promega Unveils GloMax® Galaxy Bioluminescence Imager for Illuminating Protein Dynamics in Real TimeOctober 1 • 2 min read
Promega Engineers New Enzyme to Significantly Reduce Stutter in Forensic DNA AnalysisSeptember 25 • 2 min read
Promega Fall Art Showcase Presents “From This Place: Three Photographers”August 6 • 2 min read
35th International Symposium on Human Identification (ISHI) Highlights Intersection of True Crime Media and DNA ForensicsJuly 31 • 2 min read
Promega Maxwell® DE System Accelerates Sexual Assault Kit Processing with Automated ProtocolJuly 9 • 2 min read
Promega Launches Portable 96-Well Plate Reader to Analyze Luminescent Cell Health AssaysJune 11 • 2 min read
Promega Contributes to New Study on Reversible, Non-Hormonal Male ContraceptionJune 4 • 2 min read
Promega Summer Art Showcase Presents “Collections Unveiled”May 23 • 2 min read
Promega Highlights Progress in Sustainability, Employee Wellbeing and Community Engagement in 2024 Corporate Responsibility ReportMay 22 • 2 min read
Promega Kit Enables European Forensic Labs to Solve Challenging Cold CasesMay 7 • 2 min read
INOVIQ and Promega Sign Global Supply and Distribution Agreement for EXO-NET®April 18 • 2 min read
Promega Spring Art Showcase 2024 Presents “Visions of Consciousness”February 15 • 2 min read
eLabNext Partners with Promega to Make Product Protocols Accessible for eLabProtocols UsersJanuary 16 • 2 min read
Promega Research Shows Potential of Selective Degrader Against Pediatric Cancer Cell LinesJanuary 16 • 2 min read
2023
BioLabs and Promega announce collaboration to support young biotech companiesDecember 14 • 2 min read
Promega Named a BioSpace 2024 Best Places to Work WinnerNovember 8 • 2 min read
Live-Cell Assays Reveal Two Reported Anti-Inflammation Molecules Fail to Engage Target ProteinOctober 25 • 2 min read
Promega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in collaboration with GSKOctober 3 • 2 min read
Promega Fall Art Showcase 2023 to Honor Artist Truman LoweSeptember 6 • 2 min read
CRISPR-Cas9 Knock-In Efficiency Enhanced Using Small-Molecule Inhibitor Pair, Study ShowsAugust 21 • 2 min read
Innovative research for malaria control driven by three collaborating parties: Swiss TPH, BASF and PromegaAugust 17 • 2 min read
Promega and BTC Institute D.O.O.R.S Scholarship Recognizes STEM Students from Underrepresented BackgroundsAugust 14 • 2 min read
DNA-Encoded Libraries (DELs) and NanoBRET® Target Engagement Assays Accelerate Drug DiscoveryAugust 1 • 2 min read
2023 International Symposium on Human Identification (ISHI) Keynote Offers Message of Resilience for Forensics ProfessionalsJuly 25 • 2 min read
INOVIQ and Promega announce global joint marketing agreement for EXO-NET exome isolation and nucleic acid purification solutionsJuly 6 • 3 min read
Promega Commits to 100% Renewable Electricity by 2025June 13 • 3 min read
Promega Summer Art Showcase 2023 Presents “Threads of Joy”May 23 • 2 min read
Axxam and Promega announce agreement to develop smart assays for drug discovery servicesMay 23 • 2 min read
Media Resources
For media inquiries, email us at: news@promega.com
Download company photos from our media gallery.
"At a time when some find the needs in our world overwhelming, individual efforts may feel futile, and yet, the influence of an individual is just what we need."
—William A. Linton, Chairman & CEO